The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Reads0
Chats0
TLDR
A marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping are notable.Abstract:
The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.read more
Citations
More filters
Journal ArticleDOI
Impact of Histologic Subtyping on Outcome in Lobar vs Sublobar Resections for Lung Cancer: A Pilot Study
TL;DR: The findings corroborate the prognostic significance of the 2011 adenocarcinoma subtyping classification and suggest that lobectomy does not offer an overall survival advantage over W/S regardless of histologic subtype, and suggests that limited resection may be appropriate for small size tumors.
Journal ArticleDOI
ALK rearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer.
Michael J. Neat,Nicola J Foot,Alexander Hicks,Ronan Breen,Bridget S. Wilkins,Emma McLean,George Santis +6 more
TL;DR: The suitability of fluorescence in situ hybridization and immunohistochemistry to determine ALK status in endobronchial ultrasound (EBUS)‐derived cytology samples is evaluated.
Journal ArticleDOI
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
Young-Il Kim,Joong-Won Park,Bohyun Kim,Sang Myung Woo,Tae Hyun Kim,Young Hwan Koh,Woojin Lee,Chang-Min Kim +7 more
TL;DR: XP-CCRT was well tolerated and was associated with longer PFS and OS than XP chemotherapy alone in patients with unresectable advanced IHCC, and Controlled randomized trials are required to determine whether XP- CCRT is a primary treatment option for patients with unsectableadvanced IH CC.
Journal ArticleDOI
HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study
Dan Huang,Ning Lu,Qinhe Fan,Weiqi Sheng,Hong Bu,Xiaolong Jin,Guimei Li,Yanhui Liu,Xianghong Li,Wenyong Sun,Huizhong Zhang,Xiaobing Li,Zong-Guang Zhou,Min Yan,Xuan Wang,Weihong Sha,Jiafu Ji,Xiangdong Cheng,Zhiwei Zhou,Jianming Xu,Xiang Du +20 more
TL;DR: The results suggest that IHC followed by DSISH testing is an accurate and cost-effective procedure in China and that the main reason of HER2 status discordance between local and the central laboratories was IHC result mis-interpretation in local laboratories.
Journal ArticleDOI
Circulating Endothelial-Derived Activated Microparticle: A Useful Biomarker for Predicting One-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer
Chin-Chou Wang,Chia-Cheng Tseng,Chang-Chun Hsiao,Huang-Chih Chang,Li-Teh Chang,Wen-Feng Fang,Steve Leu,Yi-Hsi Wang,Tzu-Hsien Tsai,Cheng-Ta Yang,Chih-Hung Chen,Hon-Kan Yip,Chi-Kung Ho,Meng-Chih Lin +13 more
TL;DR: Circulating EDAc-MPs may be a useful biomarker predictive of one-year morality in ES-NSCLC patients.
References
More filters
Book
AJCC Cancer Staging Manual
Mahul B. Amin,Stephen B. Edge,Frederick L. Greene,David R. Byrd,Robert K. Brookland,Mary Kay Washington,Jeffrey E. Gershenwald,Carolyn C. Compton,Kenneth R. Hess,Daniel C. Sullivan,J. Milburn Jessup,James D. Brierley,Lauri E. Gaspar,Richard L. Schilsky,Charles M. Balch,David P. Winchester,Elliot A. Asare,Martin Madera,Donna M. Gress,Laura R. Meyer +19 more
TL;DR: Purposes and Principles of Cancer Staging and End-Results Reporting are explained.
Related Papers (5)
AJCC Cancer Staging Manual
Mahul B. Amin,Stephen B. Edge,Frederick L. Greene,David R. Byrd,Robert K. Brookland,Mary Kay Washington,Jeffrey E. Gershenwald,Carolyn C. Compton,Kenneth R. Hess,Daniel C. Sullivan,J. Milburn Jessup,James D. Brierley,Lauri E. Gaspar,Richard L. Schilsky,Charles M. Balch,David P. Winchester,Elliot A. Asare,Martin Madera,Donna M. Gress,Laura R. Meyer +19 more